The National Office of Animal Health (NOAH) and the International Federation for Animal Health Europe (IFAH) have welcomed the European Commission's publication of proposals for revised legislation concerning veterinary medicines and medicated feed earlier today.
The EC says the proposals are designed to increase the availability of veterinary medicines, reduce administrative burden, stimulate competitiveness and innovation, improve the functioning of the internal market and address the issue of antimicrobial resistance.
NOAH says that currently, the manufacturers of veterinary medicines struggle with a regulatory system with some serious flaws, including:
NOAH chief executive Phil Sketchley said: "NOAH will be looking at the detail of the texts in the coming days and weeks, and reviewing their potential impact. We look forward to working with the VMD, who have called stakeholder workshops to examine the texts. We will also be supporting our European federation IFAH-Europe as they work determinedly with the European institutions over the coming years to support the Commission's vision for a more efficient regulatory system for veterinary medicines in Europe.
"We believe the value our industry brings to society is very high, despite being quite a small sector. For example, veterinary medicines benefit public health by preventing zoonotic disease and supporting food security.
"With synergies with our own UK Government's commitment to reduce unnecessary red tape, which is a key theme for DEFRA, the animal health industry in Europe needs greater efficiency to cut the red tape for our industry. We look forward to a streamlined registration process which delivers a single European marketing authorisation for all veterinary medicines.
"We will also be considering if the text has any particular implications for the UK animal health market and access to medicines for our animals."
NOAH says it also welcomes the revised medicated feed legislation. Phil Sketchley said: "NOAH believes this is an important route for administering prescription medicines to animals. We will work to help ensure the legislation is capable of maintaining and strengthening this route."
The British Equine Veterinary Association has published the results of a survey it commissioned which found that horse vets in the UK are probably at greater risk of injury than any other civilian profession, including the prison service.
For the study, which was conducted by the Institute of Health and Wellbeing and the School of Veterinary Medicine at the University of Glasgow, 620 equine vets completed a work-related injuries questionnaire. The results of the study indicated that an equine vet could expect to sustain between seven and eight work-related injuries that impeded them from practicing, during a 30-year working life.
If the 620 respondents were representative of the rest of the profession, the injuries they reported would equate to 26,452 per 100,000 equine vets in employment per year. That compares with 10,760 for people working in the prison service, 8,700 for policemen below the rank of sergeant, 6,980 for welders, metal formers and related trades, and 4,760 for construction workers.
Participants were asked to describe their worst-ever injury. Most were described as bruising, fracture and laceration, with the most common site of injury being the leg (29%), followed by the head (23%). The main cause of injury was a kick with a hind limb (49%), followed by strike with a fore limb (11%), followed by crush injury (5%). Nearly a quarter of these reported injuries required hospital admission and notably, 7% resulted in loss of consciousness. The most common reason for the examination during which the injury occurred was foot lameness, followed by dental and female reproductive.
BEVA Past-President Keith Chandler said: “We were shocked to discover the extent of the injuries sustained. Of greatest concern is the number of vets who suffered head injuries and unconsciousness. These injuries appeared to be more common when certain procedures were being performed, such as endoscopy of the upper respiratory tract, when vets are often only partly sighted while using examination equipment, or during wound management and bandage-changes, where vets are often crouched-down for long periods, next to the patient.”
38% of the ‘worst’ injuries occurred when the vet was working with a ‘pleasure’ horse and most frequently (48% of all responses) the horse handler was the owner or the client at the time of the injury. Whilst the number of laypersons or handlers injured at the same time was low, Tim Parkin, vet and lead researcher, pointed out: “This work should act as a wake up call to all involved in the training, employment and engagement of equine vets. The risks associated with handling and working with horses should be the primary consideration for equine vets and horses owners alike, every time a horse is examined or treated. In addition, the experience of the horse handler should be considered when undertaking riskier procedures.”
David Mountford, Chief Executive of BEVA said: “The results are very concerning and justify a careful prospective scientific quantification of the risks. In the short term, knowledge of these risks allows us to better inform all vets who work with horses. In turn vets will be able to inform horse owners, horse-keepers and trainers of the risks, and this may provide justification for having trained assistance on-hand or the more extensive use of sedative drugs in practice, potentially reducing the risk of injury.
"The British Equine Veterinary Association will now look to work with the Health and Safety Executive, Veterinary Schools, large employers of vets in the UK and our members to help develop policies to mitigate the risk of serious injury for vets working with horses.”
Photograph courtesy Towcester Veterinary Centre
Andrew Harrison, a partner at Three Counties Equine Hospital in Gloucestershire, has been appointed as the new President of the British Equine Veterinary Association (BEVA) for 2014/15.
Andrew took over the role from Paul Jepson at the end of BEVA Congress last week. Mark Bowen, Associate Professor of Veterinary Internal Medicine at The University of Nottingham School of Veterinary Medicine and Science, becomes President Elect.Andrew said: "It is a privilege and an honour to take up the presidential reins for the next 12 months. It is unrealistic to expect to "change the world" in such a short time frame so the plan is to target certain areas, such as progressing New Safer Horse Rescue courses, strengthening BEVA's relationship with the BHA and moving forward with the regulation of Musculoskeletal Paraprofessionals. Not least it is a priority this year to make sure we keep aspiring vets realistically informed about future employment in our profession given the proliferation of undergraduate places available at UK and English speaking mainland European vet schools."
For further information visit www.beva.org.uk.
Ceva Animal Health has launched a new initiative to help young vets attend a variety of educational opportunities to further their knowledge of cattle reproduction.
The reprodAction Young Vet Initiative was introduced this month and three young vets have already taken part in the scheme.
The new initiative is open to recently qualified vets who are keen to improve their knowledge of cattle reproduction and who work for practices that are interested in growing their business by improving cattle reproduction on farms. The scheme includes Ceva-sponsored cattle fertility courses and dissertation programmes.
Emily Denton from Shropshire Farm Vets (pictured right), Annelyse Desbois From Meadows Farm Vets and Alun Beckett from Larkmead Veterinary Group were chosen to attend a CPD day 'A Practical Approach to the Non-Pregnant Cow', organised by Nottingham University.
Carol Atkinson, Ceva's reprodAction range marketing manager, said: "The purpose of this project is to give new graduates working in practice the opportunity to participate in quality CPD. The aim is to help them build their expertise and enthusiasm for cattle reproduction work via practical sponsorship."
Emily Denton has been an intern at Shropshire Farm Vets for the past year. She was chosen for the initiative having recently completed the XL vets farm new graduate programme. She said: "It was an exciting opportunity to build on the skills I have developed in practice and to discuss cases with my peers and with other, more experienced clinicians. The course was excellent - my take home message was that as cow genetics change it affects their cycle. Our ability to manipulate this is dependent on having a good, accurate knowledge of the physiological changes taking place."
For more information about taking part in the reprodAction Young Vet Initiative, contact your Ceva Territory Manager.
The Waltham Centre for Pet Nutrition has announced new research - published in BMC Vet Research1 - which examined the progression of periodontal disease in miniature schnauzers and found that without effective and frequent oral care, dental disease developed rapidly and advanced even more quickly with age.
Over the course of 60 weeks, full mouth examinations were conducted on 52 miniature schnauzers ranging in age between 1.3 and 6.9 years. Prior to the study, each dog had a regular oral care routine that included tooth brushing. This was suspended a week before the initial dental assessment. Of the 2,155 teeth examined, all entered the study with some level of gingivitis, while only 23 teeth entered with periodontitis.
Every 6 weeks, levels of gingivitis and periodontitis were assessed around the whole surface of each individual tooth by measuring periodontal probing depth, gingival recession and furcation exposure. Teeth were assessed for the level of gingivitis (scored between 0 and 4) and periodontitis (PD1 - up to 25% attachment loss and PD2 - between 25 to 50% attachment loss). Teeth from only one dog in the study did not progress to periodontitis.
Researchers found that, without regular oral care, the majority of dogs developed the early stages of periodontal disease within six months and dogs above the age of four developed periodontal disease even faster. The degree to which periodontal disease progressed varied based on the type of tooth and location on the tooth.
Furthermore, the study showed that periodontitis developed regardless of the visible signs of gingivitis, which had previously been believed to reliably precede it. Therefore while a visual inspection may be sufficient to detect a disease like gingivitis, it is not useful in detecting the onset of periodontitis and may not reveal the areas at greatest risk for dental disease.
Dr Stephen Harris, leader of the oral care team at WALTHAM, part of Mars Petcare said: "We all want to do the very best for our pets' health, and the study showed us that there's more than meets the eye when it comes to small dogs' oral health.
"Some pet owners "lift-the-lip" and look at a dog's gums to get a sense of its oral health, but this research shows they could be missing important early signs of dental disease. The findings should encourage all dog owners to establish an oral care routine that consists of regular tooth brushing supplemented with dental chews and veterinary checks. It's important for all dogs, but we know that small dogs like miniature schnauzers are at an even higher risk of developing severe dental problems."
Reference:
Merial Animal Health has launched Allevinix, a flunixin-based non-steroidal anti-inflammatory (NSAID) pain killer for cattle, pigs and horses.
Victoria Hudson, Product Manager for Merial Animal Health said: "We have positioned Allevinix as the flexible flunixin that meets your needs, because it offers flexibility in every area.
"It is the only flunixin licensed for both intramuscular and intravenous administration in cattle and we know that this will be very welcome for many vets and farmers. It can be used across cattle, pigs and horses, and it is the first injectable NSAID to come in a durable, non-breakable bottle."
Merial says Allevinix is fast-acting against inflammation, pain and fever, reaching peak plasma levels approximately 30 minutes after injection. It is available in 100ml and 250ml PET bottles and joins Ketofen as part of a range of NSAIDs available from Merial. It can also be used in conjunction with Merial's antimicrobial treatment for calf pneumonia - Zactran.
Victoria added: "We believe that vets will find this is a useful and innovative addition to the range of options that they have in terms of NSAIDs. Allevinix has a number of advantages over other flunixin products currently on the market."
Zoetis has launched UlcerGold (omeprazole) for the treatment - and prevention of recurrence - of gastric ulcers in horses and foals, presented in a syringe suitable for foals from four weeks of age and horses from 70 to 700kg.
Equine Gastric Ulceration Syndrome (EGUS) is a serious and common condition affecting horses and foals.2,3 Approximately 90% of racehorses, 60% of performance horses, 37% of leisure horses and 50% of foals have been shown to be affected.2,4,5 The condition is associated with injury to the mucosa of the oesophagus, stomach and duodenum, with prolonged exposure to gastric acid thought to be the primary cause.2,3 Risk factors include stress, intense exercise, a high-grain diet, intermittent feeding and illness.2,3 EGUS can have a profound impact on a horse's condition and performance and can ultimately be life threatening, especially in foals.3,5 It is a challenging condition to diagnose as the clinical signs are often vague and not always present.3 Gastroscopy is the only method currently available for a definitive diagnosis and treatment is usually based on acid suppressive therapy to allow ulcer healing.2
UlcerGold is indicated to treat and prevent the recurrence of gastric ulcers in horses, administered once-daily for 28 consecutive days at the full dose of 4mg/kg bodyweight followed by the reduced dose of 1mg/kg bodyweight for a further 28 days.1 It contains omeprazole, a proton pump inhibitor that suppresses gastric acid secretion.1,2 One syringe contains enough UlcerGold for a horse weighing up to 700kg. It can be used for foals as young as four weeks of age that weigh over 70kg and for breeding stallions.
Zoetis says UlcerGold is supported by a comprehensive gastroscope training programme, pricing model, client support and communications plan to ensure that it is a strong asset to veterinary businesses.
Penny McCann, Equine Product Manager, Zoetis UK Ltd, said: "UlcerGold is an exciting addition to our equine POM-V portfolio. We have designed a training, education and business programme to help practices make sure they get the best from our new product, not only in terms of gastric ulceration treatment but also practice health."
References
The RCVS has published its 2014 Survey of the Veterinary and Veterinary Nursing Professions, a snapshot of the demographics of the profession, and the educational and work status of its members.
The results, which gauge individual views on the current state of the profession, are used to inform the College's future policy and activities.
6,988 veterinary surgeons (27% of the profession), 3,612 registered/listed veterinary nurses (31% of the profession) and 1,792 student veterinary nurses took part in the surveys, which are conducted once every four years by the Institute for Employment Studies.
This year's surveys included a set of questions about 24-hour emergency cover, which contributed to the recent review of the College's guidance in this area, and, for the first time, questions from the government-backed Social Mobility Toolkit, which aim to assess the social background of members of the profession.
Highlights from the survey of veterinary surgeons included:
Highlights from the survey of veterinary nurses included:
Both the Survey of the Veterinary Profession and the Survey of the Veterinary Nursing Profession, together with a report that brings together common themes, can be downloaded from the RCVS publications page.
BCF has announced the launch of the wireless Cuattro Slate 4 equine DR system.
BCF says the new system is available with an Automatic Exposure Detection (AED) panel, which means the plate automatically recognises the radiation from the generator, with no need for a sync cable.
Gavin Mitchell from BCF said: "This system now makes the connection from any generator to the plate and from plate to tablet now wireless. This is the new revolution for equine DR. Our rugged tablet design makes it easy to show your client your images. All you need to carry with you is the plate, tablet and generator. So much lighter to transport than previous DR systems and now also easier to move around the horse."
Sarah O'Grady from BCF added: "The powerful Cuattro software is so intuitive to use, allowing you to easily customise how your image looks. A simple three step process to take an image and just one button press to back-up images to PACS or the Cloud, makes the Slate so easy to use. If you are considering upgrading to DR or replacing your old DR system, then make sure you try out the new Slate 4."
For more information, visit www.bcftechnology.com or ask your local Account Manager for a free trial.
Novartis Animal Health has announced the results of a survey of dairy and beef farmers which found that 39% of those who found Bovine Viral Diarrhoea (BVD) present in their herd did not then go on to test for persistently infected (PI) animals.
Any calf born from a BVD persistently-infected cow will be born Persistently Infected with the virus and cannot be cured. As a result, future vaccination of this animal against the virus is rendered ineffective and the affected animal will be a source of the virus, spreading infection within the herd.
With young cattle being the source of PI's and reservoirs of infection within a herd, failure to test, identify and then deal with PI livestock represents the most significant problem facing the industry when trying to eradicate BVD.
Professor Joe Brownlie from the Royal Veterinary College and current chairman of the BVD Scientific and Technical Working Group, said: "Of the 61% of farmers that did do follow up tests for PI's once BVD had been detected in their herd, one third found one or more PI's within the stock holding.
"However, one third of farmers who identified having active BVD infection in their herd then failed to go on and carry out individual animal testing; of those that did, nearly half discovered one or more individual PI's within their herd".
"It just shows that the disease can be hidden, and farmers could be in the dangerous position of potentially missing PI animals that are in their herd; PI's that can continue to spread the BVD virus amongst other cattle and pass on their PI status to any calves they produce. It is hugely important to be thorough and consistent in your testing as part of an agreed herd health plan"
The survey also indicated that action needs to be taken to educate farmers about what to do once BVD and, most significantly, PI's are discovered amongst a herd.
Professor Brownlie said: "There is much evidence from this survey to encourage the industry in how it is tackling this disease, however there is still a great need for clear direction. The survey indicated that 20% of farmers wrongly believe that PI animal's will eventually become non-infective and that 25 % believe that calves born of PI cows will not always have PI calves themselves.
"All of these perceptions are incorrect and can lead to reservoirs of the disease being allowed to remain not only within individual herds, but geographical regions as well; seriously hindering the eradication of the virus in England and Wales".
With nearly half of farmers saying that they talked to vets - their main source of information about BVD - only once or less a year, Professor Brownlie said it is unsurprising that many farmers did not show a greater understanding of BVD beyond biological side effects present in the infected cattle: "About 50% of farmers surveyed were unsure as to what types of tests need to be carried out to detect the infection in their livestock and 32% of respondents were unaware that correct vaccination of livestock against BVD can protect both the cow and unborn calf".
Novartis says that while BVD is still regarded by farmers as one of the top bovine diseases, other health issues such as mastitis and tuberculosis are given much greater attention. This lack of focus on BVD is exacerbated by the lack of sound information of the financial implications of the infection on their herd.
Professor Brownlie said: "The side effects of BVD appear to be overlooked in financial terms, but the infection can severely hinder a herd's financial productivity due to poor health, reduced milk yield and loss of reproductive efficiency.
Caroline Dawson from Novartis Animal Health said:"Perhaps by aiding understanding of the financial cost of the virus, we can encourage farmers to take more proactive steps to combat BVD. As such, I am pleased to announce that that the FAB panel has initiated a follow on project to carry out detailed research with regards to the financial impact of BVD on farms and is due to report findings in the new year".
(Photograph shows, left to right, James Russell MRCVS (McMurtry & Harding), Caroline Dawson (Novartis Animal Health), Tony Brooks (Brighthams Farm), Professor Joe Brownlie(RCVS)
Norbrook Laboratories has announced the addition of new indications to its Loxicom (meloxicam) products, two regarding its use in cats, and the other in calves.
Loxicom 5mg/ml solution for injection for dogs and cats is now indicated for the management of post-operative pain in cats. An injection given around the time of surgery can be followed up with a course of Loxicom 0.5 mg/ml oral suspension for cats. Alternatively, for cats where no follow-up oral treatment is possible, for example with feral cats, a larger dose of the injectable formulation can be given at the time of surgery.
Norbrook's EU Veterinary Advisor, Rebekah Dudek MRCVS, said: "Norbrook is pleased to be able to now offer vets two on-licence choices in relation to how they want to use their 5mg/ml meloxicam injection in cats. This gives vets the flexibility they need to be able to deal effectively with the wide variety of cases they see every day."
Loxicom 20mg/ml solution for injection for cattle, pigs and horses has now been licenced for the relief of post-operative pain following dehorning in calves.
Norbrook says that the use of a non-steroidal antiinflammatory drug (NSAID) alongside local anaesthetic has clear benefits for animal welfare, and that use at this time is also shown to offer economic benefits to the farmer, with increased food-conversion efficiency compared to untreated calves1.
Rebekah said: "Dehorning in calves has long been known as a painful procedure, with a negative impact on feed intake in the post-operative period. With our latest licence, Loxicom 20mg/ml can now be used for relief of this potentially economically important post-operative pain in calves."
Reference
Avacta Animal Health and the University of Leicester have announced the development of a new, user-friendly electronic system for diagnosing lymphoma in dogs in the early stages, and for remission monitoring.
Marketed as cLBT (canine lymphoma blood test), this is the first test of its kind to track the remission monitoring status of a dog after undergoing chemotherapy. The test detects the levels of two biomarkers, the acute phase proteins C-Reactive Protein and Haptoglobin.
The new test represents the fruits of a collaboration between Avacta and the University of Leicester in which the company collected a substantial library of biological samples, and the University then brought its statistical and data processing techniques to bear.
Alexander Gorban, Professor of Applied Mathematics at the University of Leicester, said: "This was a very interesting project, and Avacta was a very dedicated, focused company, with clear goals and objectives. There were very important and useful ideas and concepts involved in the study, and it was a pleasure to know that our expertise as a department was needed and could be utilised through working alongside Avacta's professional expertise.
"The project was very successful, and we would be very glad to welcome more partnerships of this type as it has also been very beneficial to the reputation of the University of Leicester's Department of Mathematics. The project involved full academic and commercial success, which has included a full academic cycle as well as full software development, which makes it an incredibly diverse project to have worked on."
Chief Scientific Officer at Avacta Animal Health, Kevin Slater, said: "The collaboration we have with the University of Leicester's Department of Mathematics is having a dramatic impact on the types of new tests that we can offer to vets and their owners. We are already widening the application of multivariate analysis to other diseases which commonly affect our pets, and subsequently, this work could also have benefits to human health."
The paper 'Computational diagnosis and risk evaluation for canine Lymphoma' by E.M. Mirkes, I. Alexandrakis, K. Slater, R. Tuli and A.N. Gorban has been published in the academic journal Computers for Biology and Medicine and is available at the following location: http://dx.doi.org/10.1016/j.compbiomed.2014.08.006
Vétoquinol, makers of Zylkène, a complementary feed for cats and dogs, has launched www.zylkenepet.co.uk, a new website with advice for pet owners about how they can help their pet deal with unsettling situations.
The website offers a behavioural quiz to help identify whether a pet may need help coping with any changes taking place. In addition, the site offers tips and advice from behavioural experts together with guides to helping pets cope with situations such as moving home, the introduction of a new baby or new people, travelling and holidays, coping with kennel and cattery stays and fireworks.
Krystyna Joyce, Product Manager at Vétoquinol, said: 'Owners often give Zylkène when their pet needs a bit of extra support to deal with unusual situations and changes to their routine, but there are also lots of practical things you can do that will improve a pet's experience further during that time. We wanted to make sure that information was readily available through a succinct, user friendly website.'
The British Small Animal Veterinary Association has announced that it is offering a new, enhanced legal service for its members, in conjunction Harrison Clark Rickerbys.
From 1st October, BSAVA members will be able to benefit from discounted rates and special fixed-fee packages for their personal and professional legal needs.
The BSAVA says that Harrison Clark Rickerbys' specialist team has a vast experience of acting for small animal veterinary practices, as well as referral practices and animal hospitals throughout the UK.
Charlotte Thornton-Smith from Harrison Clark Rickerbys said: "The team is delighted to provide dedicated membership benefits to the BSAVA and keen to work with its members to advise on any of their legal issues. We have a longstanding relationship with the BSAVA which stretches back over twenty years and have substantial experience of acting for veterinary practitioners, both personally and professionally. We very much hope that members of the BSAVA will take advantage of the special packages and discounted rates we are offering."
For more information, visit www.bsava.com
The International Federation on Ageing has published Companion Animals and the Health of Older Persons, a report described as the most extensive literature review to date of research undertaken in the field of companion animals and the health of older people, made possible through an educational sponsorship from Bayer Healthcare.
The report provides a comprehensive literature review into the ways pets contribute to the physical and mental health of individuals and the well-being of our broader society, citing studies which found:
Dr Jane Barratt from the International Federation on Ageing said: "This field of research has important implications across generations and also for the future of our broader society. Many studies have broadly discussed how pets, such as dogs and cats, contribute to health by reducing anxiety, loneliness and depression, but until today, have not yet been published in a single resource. This new report advances our understanding of the value of companion animals in the framework of human health and the broader society."
In the report, investigators acknowledge that the current data on human-companion animal interactions are often predicated on anecdotal evidence and scant qualitative and quantitative data, with poorly-constructed and poorly-controlled study design. This may account in part for the conflicting results found in a number of different studies. Nonetheless, they argue that based on current evidence of considerable positive potential for the health of older individuals, and the associated health and welfare benefits for local communities and societies, more research time and energy should be directed towards this area of research. In particular, they say, there should be much greater involvement from veterinary surgeons, who are well placed to be consulted in studies of companion animals and older people’s attachment, affection and bonding capacities, well-being and social capital.
Ferenc Polz, Head of Bayer Animal Health said: "The therapeutic benefit of companion animals is an area of study attracting increasing interest among health and social science professionals and this sponsored report is yet another example of the life changing potential of human and animal relationships."
CVS Group has announced that European internal medicine specialist Caroline Kisielewicz MVB CertSAM DipECVIM-CA is joining ChesterGates Veterinary Specialists with effect from 1 October 2014.
Caroline Kisielewicz graduated from University College, Dublin in 2006 and, after working in first opinion small animal practice for two years, completed an ECVIM-residency training programme at the Small Animal Hospital at the University of Glasgow in February 2013.
Most recently she has been working at the Queen Mother Hospital for Animals at the Royal Veterinary College. She is interested in all aspects of small animal internal medicine, particularly emergency medicine, transfusion medicine, immune-mediated diseases and endocrine diseases.
CVS Referral Director, Professor John Innes said: "We are delighted to welcome Caroline to our specialist team at ChesterGates. She is a rising star in internal medicine and I believe it is a measure of CVS' growing reputation for offering a diverse range of career options that we are attracting some of the strongest talent from the specialist vet pool.
"Caroline joins Ellie Mardell and Chris Saul here at ChesterGates to help us to offer an even more comprehensive and user-friendly internal medicine service."
Caroline said: "I was keen to join this excellent multi-disciplinary specialist referral hospital with its dynamic, friendly and close-knit team. Working at ChesterGates gives me the opportunity to provide the highest standard and quality of care and treatment for my patients, clients and their referring vets."
A survey conducted earlier this year by Novartis Animal Health1 has shown that owners of dogs diagnosed with atopic dermatitis want to learn more about the condition after their veterinary consultation.
When asked about what would help them understand and cope with their dog receiving a diagnosis of atopic dermatitis, 42% of dog owners said that they want reliable information about the condition on the Internet that they can read at their own pace. 27% said that hearing or reading about case studies of dogs that were diagnosed with atopic dermatitis would be a source of help and reassurance.
That isn't to take anything away from the importance of the relationship between owner and vet: 49% of respondents said that having enough time to discuss everything with their vet is the most important thing following a diagnosis of atopic dermatitis.
However, the reality of busy small animal practice means that some vets are apparently finding themselves short of time, with 62% saying that they would like to have more time in consultations to explain the diagnosis fully.
To support both vets and owners, Novartis has produced a range of education materials available at www.itchfreepet.co.uk. They include information about a variety of skin conditions in dogs and cats, including causes, clinical signs, diagnostics and treatment options, which can all be used to support recommendations made during consultations.
Novartis says it is also continuing to support vets with the 'Comfort Club' scheme, through which owners get the 2nd, 6th and 12th month of Atopica treatment free of charge. The club also allows clients to try other dermatology products that might help their pet's condition free of charge, including shampoo, EFA's and specialist diets.
Ricardo Garvao, category manager at Novartis said: "By providing reliable information and tools to help re-iterate and expand on the information given to owners by their vets, we hope to help both parties make the most of the face to face time that they have with each other. Ultimately this will strengthen the vet-client relationship, which can only improve long-term clinical outcomes.
"Good client education is vital, demonstrated by the fact that nearly a quarter (23 per cent) of pet owners that admit to giving up on their vet's advice claim that this is because they haven't understood it. A large part of the trust building process is being able to recommend a management strategy with proven efficacy and safety data for long-term use, such as Atopica. Atopica has been keeping dogs with atopic dermatitis comfortable for a decade due to its proven ability to safely provide long-term reduction of pruritus and skin lesions associated with the disease, as demonstrated by the recently published independent paper 'The use of ciclosporin: a decade of experience in veterinary dermatology."
Ceva Animal Health has produced a new advisory leaflet about enzootic abortion control and vaccination strategy in sheep to help vets explain the best prevention protocols to clients.
According to the company, it is estimated that around half of the 400,000 infectious abortions in UK sheep each year are from enzootic abortion caused by Chlamydophila abortus, but timely vaccination programmes can prevent such dramatic losses.
The eight-page leaflet explains how enzootic abortion can spread, why prevention is better than cure, the importance of timely vaccination of ewe lambs and replacement stock, how vaccination programmes make good economic sense and the benefits of using Cevac Chlamydia, Ceva Animal Health's live enzootic abortion vaccine as part of the control programme.
Carol Atkinson, reprodAction's product manager said: "Cevac Chlamydia receives consistently good feedback from vets, many of whom have enthusiastically volunteered their praise for the product to our territory managers. We thought a leaflet would be a constructive way to share views, giving vets the chance to hear about the advantages of vaccination and to provide them with the tools to explain to their clients why vaccinating against enzootic abortion is cost worthy."
For further information contact Ceva Animal Health Ltd, Unit 3, Anglo Office Park, White Lion Road, Amersham, Bucks, HP7 9FB, Telephone +44 (0) 1494 781510.
Zoetis (maker of Cerenia, the anti-emetic) is using social media for its latest campaign to remind owners that vets have a solution for dogs that suffer from travel sickness.
The company highlights research which shows the problem is more common than one might think, with 62% of dogs experiencing travel sickness for the first time as puppies. What's more, 1/3rd of owners say they would travel with their dogs more often if they didn't get car sick.
Stephanie Smith, Marketing Manager for Cerenia said: "While less than half of vets in the UK report seeing at least one canine motion sickness case each month, we know that over one third (34%) of dogs that travel experience motion sickness. That's a lot of opportunity for vets to provide pets and owners with some relief."
To spread the word, the company has set up an educational microsite: www.nonstoptravelfun.co.uk which it is now promoting with an online social media campaign, including twitter #nonstoptravelfun and targeted bloggers and pet sites. The company has also been advertising the microsite on Facebook and Google, which I'm told has driven thousands of visitors over the past fortnight.
Stephanie added: "Motion sickness can impact the whole family, making travelling an unpleasant experience. Our new campaign aims to raise awareness for the issue and encourage pet owners to seek veterinary help for the problem, so they can enjoy non-stop travel fun, without the sickness."
Zoetis has announced the availability in the UK and Ireland of Poulvac IBQX, the first specific vaccine against the QX strain of the infectious bronchitis virus.
For the past two years the vaccine has only been available with a special import certificate from the Veterinary Medicines Directorate for use on flocks where the QX virus has been isolated.
According to the company, this variant IB strain has been an increasing problem in European countries over the last 10 years and was first seen in the UK in South-East England in 2007. Since then QX has been isolated from a number of commercial layer and broiler flocks, leading to inferior performance and increased mortality.
James Porritt, Zoetis Poultry Manager for the UK and Ireland said: "Poulvac IB QX adds another protection dimension to our extensive IB vaccine portfolio. The Zoetis IB portfolio offers the widest choice and with Poulvac IBMM + ARK we have the UK's only bivalent live vaccine licensed for day-old use providing a Massachusetts strain and protection against 793/B/91 variant type strains lasting for six weeks post vaccination. Other IB Vaccines include Poulvac H120 and the UK's only other bivalent live vaccine Poulvac IB Primer."
Poulvac IB QX vaccine is based on a live attenuated virus and is administered as a coarse spray to broilers from day-old and to layer pullets or broiler breeders from seven days of age. Protection has been demonstrated by challenge study to last for 63 days after vaccination.
Zoetis says the vaccine is often used on the farm, but can be administered to chicks at the hatchery if adequate controls are in place to avoid spread to other chicks that will be moved to non-QX exposed flocks.
Dr Stuart Andrews, Poultry Veterinary Manager for Zoetis said: "In countering the QX virus strain some existing vaccines have been used to provide a degree of cross-protection. However, it is important to appreciate that Poulvac IB QX is a vaccine homologous to any IB QX field strain and so will provide even better protection.
"Furthermore, our in-house PCR and DNA sequencing service allows us to monitor carefully the field situation to ascertain which IB strains are currently causing field outbreaks and enable us to recommend adaptations to particular vaccination programmes.
"The full approval for the Poulvac vaccine will make it easier and more effective to tackle specific QX infections without having to apply for an import certificate."
Researchers from the University of Bristol have published the results of a study which has identified risk factors for syringomyelia (SM) and which could help breeders select away from characteristics which predispose dogs to the disease.
Syringomyelia, which more commonly affects toy breeds such as the Cavalier King Charles Spaniel and the Chihuahua, causes fluid-filled cavities in the spinal cord. In these toy breeds, SM is usually secondary to a specific malformation of the skull called Chiari-like Malformation (CM).
The research looked at the relationship between head shape and the incidence of CM/SM. Dogs were measured in several countries using a standardised "bony landmark" measuring system and photos analysed by researchers.
The researchers found two significant risk factors associated with CM/SM in the skull shape of the CKCS: brachycephaly (the broadness of the top of skull relative to its length) and the distribution of doming of the skull. The study suggests that brachycephaly, with resulting doming towards the front of the head, is associated with CM/SM.
Thomas Mitchell, the undergraduate student who conducted the study under the supervision of Dr Clare Rusbridge, said: "Dog breeders are very experienced at selecting for a certain conformation or appearance in dogs. Our findings may allow breeders to select away from the condition over fewer generations by choosing appropriate matings and offspring to continue breeding programmes. The identification of an appearance that might protect against developing the disease is a significant step forward in tackling this painful condition.
"The study also provides guidance to breed clubs, breeders and judges that have a responsibility to avoid obvious conditions or exaggerations which would be harmful in any way to the health, welfare or soundness of the breed. It will also provide vets with verified advice to provide to breeders outside the show ring and to occasional hobbyists."
The study has been published online in the journal Canine Genetics and Epidemiology, and a video animation which shows the differences in head shape is available on YouTube.
The work was funded by a grant from the Kennel Club Charitable Trust and the Companion Cavalier Club provided a grant for the publication of the research.
The Webinar Vet has announced that booking has opened for its third annual online webinar congress, with early bird discounts of up to 61% available for a limited time.
The 2015 congress will take place over 24 hours, with continuous lecture streams starting at midnight GMT on Saturday 10th January. Topics include soft tissue surgery, diagnostic imaging, immune-mediated skin disease, haematology and feline and canine liver disease. All sessions will also be available for those delegates who can't take part in the live event (or don't feel like doing 24 hours of CPD in one sitting) to watch on demand later.
The Webinar Vet founder Anthony Chadwick MRCVS said: "The event has developed very quickly, from the first congress staged in January 2013 attracting over 360 vets from 26 countries, followed in 2014 by the addition of a virtual exhibition and 561 delegates from 42 countries."
For more information, visit www.theinternationalwebinarvet.com.
Royal Canin has announced that it has established a team of three specialist advisors to work directly with veterinary practices to help develop and improve their weight management clinics, client retention and product sales.
The Pet Weight Care Team will also provide practical training to all practice staff on how to recognise weight problems, communicate sensitively with pet owners and treat the problem effectively.
The first advisor to join the team is Shelley Holden VN (pictured right), who has 10 years' experience as the nurse for the Royal Canin Weight Management Referral Clinic at The University of Liverpool. Shelley has spent time running successful nursing clinics in general practice and lecturing internationally on the topic of obesity. She said: "I have spent many years dedicating my time caring for overweight pets, and the number of cases we see is continuing to rise. It's really important that as obesity specialists we can offer hands-on support to practices to assist them with helping to decrease the number of overweight pets they see.
"Our aim will be to offer specialist training through a number of sessions to practices who wish to improve their weight management clinics. We'll spend time with all members of staff helping them to feel more confident when dealing with owners who have overweight pets. The training will include all aspects of weight management including how to approach owners, Body Condition Scoring and the 30 minute consult. Staff will also be trained on how to support owners throughout the weight loss program and during the maintenance phase."
Royal Canin says the training will also cover the prevention of obesity in pets, how to advise owners on the appropriate diets post neutering and how to manage the animal's weight and calorie intake throughout their lives. The Pet Weight Care Team will be encouraging practices to carry out weight management assessments alongside medical examinations to ensure that potential weight problems are dealt with quickly.
The company says that practices that receive training will be followed up with on a regular basis to provide further support and training as needed.
For more information, contact your Royal Canin Veterinary Business Manager.
Zoetis has launched a new training programme for veterinary practices which explores every aspect of the 'client journey' - from 'pre-owner' to 'Lost' - and explains how to deliver an outstanding client experience.
The Client Experience Development Programme is divided into nine training modules which vary in length from one to five and a half hours. The whole programme can be completed in two days under the guidance of a Zoetis business consultant.
The programme breaks down each element of the client journey, from attracting new pet owners into the practice and making the right impact on new customers, to keeping long-term customers loyal.
Nick Steele, national consulting manager at Zoetis, said: "We believe that calling a practice's pet owners clients or customers is a misnomer. They are consumers because they not only purchase a practice's products and services but they also experience them and the consumer's interpretation of their experience can really affect the brand. What's more, the reality of today's information-rich environment is that consumers can experience a practice without the practice even knowing about it.
"Google have coined the term 'Zero moment of truth', which alludes to all the different points of contact a consumer can have with a product or service before physically experiencing it. The average shopper uses 10.7 different sources of information before making a decision on what product or service to use.¹ This means they may have disregarded a practice before the practice knew the consumer even existed."
The concept of the client experience is introduced with some interesting statistics which emphasise its importance. For instance, a typical business hears from only 4% of its dissatisfied customers, 96% just go away and 91% will never come back². What's more, a dissatisfied customer will tell 9-15 people about it and approximately 13% will tell more than 20 people about their problem.³
Drawing on concepts like 'The Fred Factor', which focuses on four key principles of customer care, the training programme explains how every employee can make the difference from the moment clients arrive.
Nick added: "Consumers are all powerful to veterinary practices so it is essential that the client experience is an exceptional one. Our business consultants have been trained to deliver the Client Development Programme to all types of veterinary practice to ensure that they attract as many clients to the practice as possible and keep those clients happy once they are there."
For more information about Business Consulting from Zoetis telephone 0845 519 4977 or contact your account manager.
Merial is inviting all equine veterinary surgeons that are going to BEVA Congress this year to the launch of updated ProteqFlu, its equine flu vaccine which now includes protection against the latest Clade 2 strains, including Richmond 07.
Speakers at the event include specialist Dr Richard Newton (pictured right), Head of Epidemiology and Disease Surveillance at the Animal Health Trust (AHT), and Dr Romain Paillot Head of Immunology at the AHT. Dr Newton will explain why the inclusion of the Clade 2 strain is so important for horse health, and the equine industry as a whole.
Louise Radford MRCVS from Merial said: "We're all incredibly excited as the event will mark the launch of the UKs first and only fully updated equine flu vaccine that contains both a Clade 1 and Clade 2 antigen. The new ProteqFlu® vaccine fully represents the latest 2014 OIE recommended EIV strains."
The launch is being held at the Hotel Du Vin, Birmingham on Thursday 11 September 2014. Presentations will cover 'A virological and immunological perspective on Clade 2 & EIV', 'How technology makes the difference' and independent vaccine trial results.
The evening starts at 6.30pm and includes dinner and evening entertainment.
To book, contact, Jo Gater-Willats, or Merial Customer Support on 0800 6000123.